14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:FPRX
Delisted

Five Prime Therapeutics Stock Price (Quote)

$38.00
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $38.00 $38.00 Friday, 27th May 2022 FPRX stock ended at $38.00. During the day the stock fluctuated 0% from a day low at $38.00 to a day high of $38.00.
90 days $38.00 $38.00
52 weeks $38.00 $38.00

Historical Five Prime Therapeutics prices

Date Open High Low Close Volume
Mar 17, 2022 $38.00 $38.00 $38.00 $38.00 0
Mar 16, 2022 $38.00 $38.00 $38.00 $38.00 0
Mar 15, 2022 $38.00 $38.00 $38.00 $38.00 0
Mar 14, 2022 $38.00 $38.00 $38.00 $38.00 0
Mar 11, 2022 $38.00 $38.00 $38.00 $38.00 0
Mar 10, 2022 $38.00 $38.00 $38.00 $38.00 0
Mar 09, 2022 $38.00 $38.00 $38.00 $38.00 0
Mar 08, 2022 $38.00 $38.00 $38.00 $38.00 0
Mar 07, 2022 $38.00 $38.00 $38.00 $38.00 0
Mar 04, 2022 $38.00 $38.00 $38.00 $38.00 0
Mar 03, 2022 $38.00 $38.00 $38.00 $38.00 0
Mar 02, 2022 $38.00 $38.00 $38.00 $38.00 0
Mar 01, 2022 $38.00 $38.00 $38.00 $38.00 0
Feb 28, 2022 $38.00 $38.00 $38.00 $38.00 0
Feb 25, 2022 $38.00 $38.00 $38.00 $38.00 0
Feb 24, 2022 $38.00 $38.00 $38.00 $38.00 0
Feb 23, 2022 $38.00 $38.00 $38.00 $38.00 0
Feb 22, 2022 $38.00 $38.00 $38.00 $38.00 0
Feb 18, 2022 $38.00 $38.00 $38.00 $38.00 0
Feb 17, 2022 $38.00 $38.00 $38.00 $38.00 0
Feb 16, 2022 $38.00 $38.00 $38.00 $38.00 0
Feb 15, 2022 $38.00 $38.00 $38.00 $38.00 0
Feb 14, 2022 $38.00 $38.00 $38.00 $38.00 0
Feb 11, 2022 $38.00 $38.00 $38.00 $38.00 0
Feb 10, 2022 $38.00 $38.00 $38.00 $38.00 0
Click to get the best stock tips daily for free!

About Five Prime Therapeutics

Five Prime Therapeutics Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes in the United States. The company’s product candidates include FPA008, an antibody that inhibits colony stimulating factor-1 receptor and is in Phase Ia/Ib clinical trials for the treatment of various cancers in combination with nivolumab; and is in Phase I/II... FPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT